Produkty 1386162-69-1

CAS 1386162-69-1 występuje w naszej ofercie pod nazwami: ML417/ 98.81% (existing batch purity), ML417, ML417 99%, (1H-indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone, ≥98%, ≥98%, ML417, 99.50%. Oferty producentów: TargetMol, GLPBio, Biosynth, Ambeed, Chemat. Dostępne opakowania: 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 10mM (in 1ml dmso), 1mg.

ML417/ 98.81% (existing batch purity)
TargetMol
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 6
od 405,71
Zobacz produkt
ML417
GLPBio, Biosynth
  • opakowanie: 10mg, 100mg, 10mM (in 1ml dmso), 5mg
  • Warianty: 7
od 793,62
Zobacz produkt
ML417 99%
Ambeed
  • opakowanie: 1mg, 5mg, 10mg, 50mg
  • Warianty: 6
od 253,56
Zobacz produkt
(1H-indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone, ≥98%, ≥98%
Chemat
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 218,00
Zobacz produkt
ML417, 99.50%
MedChemExpress
  • opakowanie: 100 mg, 25 mg, 10mM/1mL, 10 mg
  • Warianty: 6
od 324,34
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

1H-indol-2-yl-[4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl]methanone (CAS 1386162-69-1) to związek chemiczny o wzorze sumarycznym C22H25N3O3 i masie molowej 379.5 g/mol. Nazwa systematyczna IUPAC: 1H-indol-2-yl-[4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl]methanone. InChIKey: HAZPAMUWUHDPDA-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H25N3O3
Masa molowa379.5 g/mol
Nazwa IUPAC1H-indol-2-yl-[4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl]methanone
InChIKeyHAZPAMUWUHDPDA-UHFFFAOYSA-N
SMILESCOC1=CC=C(C=C1)OCCN2CCN(CC2)C(=O)C3=CC4=CC=CC=C4N3

Dane obliczone przez PubChem (NCBI)

Synonimy: (1H-Indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone, 1H-indol-2-yl-[4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl]methanone, orb1298946, 2-{4-[2-(4-methoxyphenoxy)ethyl]piperazine-1-carbonyl}-1H-indole, (2-Indolyl)[4-[2-(4-methoxyphenoxy)ethyl]-1-piperazinyl]methanone, Methanone, 1H-indol-2-yl[4-[2-(4-methoxyphenoxy)ethyl]-1-piperazinyl]-
Izomery (ten sam wzór sumaryczny)
(1S,12S,15S)-7-methoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione C22H25N3O3
4-(2-oxa-6,13,20-triazapentacyclo[12.8.0.03,12.05,10.016,21]docosa-1(14),3(12),4,10,15,21-hexaen-6-yl)butanoic acid C22H25N3O3
N-methyl-2-(3-nitrophenyl)-N-[(1S,2S)-2-pyrrolidin-1-yl-2,3-dihydro-1H-inden-1-yl]acetamide C22H25N3O3
5-[3-(2-phenylpropan-2-ylcarbamoyl)pyrrolo[2,3-b]pyridin-1-yl]pentanoic acid C22H25N3O3
(E)-N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide C22H25N3O3
8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one C22H25N3O3
3-(4-benzo[b][1,4]benzoxazepin-6-ylpiperazin-1-yl)-2,2-dimethylpropanoic acid C22H25N3O3
1-[4-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]phenyl]-3-prop-2-enylurea C22H25N3O3
7-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-5H-[1,3]dioxolo[4,5-f]indole C22H25N3O3